The ABL kinase inhibitor STI571 does not affect survival of hematopoietic cells after ionizing radiation

Blood. 2000 Nov 1;96(9):3294-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Benzamides
  • Cell Survival / drug effects*
  • Cell Survival / radiation effects
  • Genes, abl
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / radiation effects
  • Humans
  • Imatinib Mesylate
  • Piperazines / pharmacology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Proto-Oncogene Proteins c-abl / antagonists & inhibitors*
  • Pyrimidines / pharmacology*
  • Radiation, Ionizing
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-abl